13G Filing: Balyasny Asset Management and Sunesis Pharmaceuticals Inc (SNSS)

Page 22 of 30

Page 22 of 30 – SEC Filing


(c) Number of Shares as to which person has:
(i) Sole power to vote or to direct vote:
224,506
(ii) Shared power to vote or to direct vote:
None
(iii) Sole power to dispose or direct disposition of:
224,506
(iv) Shared power to dispose or to direct disposition of:
None
AEMF
(a) Amount Beneficially Owned:
1,310,494
(b) Percent of Class:
6.11%
(c) Number of Shares as to which person has:
(i) Sole power to vote or to direct vote:
1,310,494
(ii) Shared power to vote or to direct vote:
None
(iii) Sole power to dispose or direct disposition of:
1,310,494
(iv) Shared power to dispose or to direct disposition of:
None

Page 22 of 30 Pages

Follow Viracta Therapeutics Inc. (NASDAQ:VIRX)

Page 22 of 30